Amy Burroughs's Insider Trades & SAST Disclosures
Amy Burroughs's most recent trade in Terns Pharmaceuticals Inc was a trade of 1,075,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Amy Burroughs.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 1,075,000 | 1,075,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Amy Burroughs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 30 Jan 2025 | 510 | 19,609 | - | 5.1 | 2,606 | Common Stock |
| Terns Pharmaceuticals Inc | Amy Burroughs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.15 per share. | 05 Dec 2024 | 15,450 | 19,099 | - | 7.2 | 110,468 | Common Stock |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Terns Pharmaceuticals Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,250,000 | 1,250,000 | - | - | Stock Option (Right to buy) | |
| Terns Pharmaceuticals Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 150,000 | 150,000 | - | - | Restricted Stock Unit | |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 14,766 | 14,766 | - | - | Stock Option (Right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 1.53 per share. | 03 Jan 2023 | 17,156 | 73,288 (0%) | 0% | 1.5 | 26,249 | Voting Common Shares, no par value per share |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 3.58 per share. | 03 Jan 2022 | 11,182 | 56,132 (0%) | 0% | 3.6 | 40,032 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 16 Aug 2021 | 44,950 | 44,950 (0%) | 0% | 3.2 | 141,593 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 18,786 | 18,786 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges